መነሻ › ማኩላር ዴጀነሬሽን › Ohio
በOhio ለማኩላር ዴጀነሬሽን የሚደረጉ ክሊኒካዊ ጥናቶች
ለማኩላር ዴጀነሬሽን የሚደረጉ 11 ጥናቶች በOhio ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በOhio ውስጥ ያሉ ከተሞች
Official study text (English)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
- Cincinnati Eye Institute (Site 133), Cincinnati
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
እድሜ 50 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT07440225A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Cincinnati Eye Institute, Cincinnati
- Cleveland Clinic Main Campus, Cleveland
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
እድሜ 60 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT06635148A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
- Retina Associates of Cleveland - Beachwood, Beachwood
- Retina Associates of Cleveland, Cleveland
- Retina Associates of Cleveland - Middleburg Heights, Middleburg Heights
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 55 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT07029945A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Cincinnati Eye Institute, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
- The Ohio State University, Columbus
- እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ50 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ18 ሴፕቴ 2026 · NCT06541704A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions
- Cincinnati Eye Institute, Cincinnati
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 6 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT07734064Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Cleveland Clinic Foundation-Cole Eye Institute, Cleveland
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 55 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT06659445Noninvasive Imaging Biomarkers of Treatable Macrovascular Disease in Age-related Macular Degeneration.
- Cleveland Clinic, Cleveland
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ50 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT07798323Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
- Retina Associates of Cleveland, Beachwood
ተሳታዮችን በመፈለግ ላይ
እድሜ 60 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ26 ኦገስ 2026 · NCT06662162A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
- Cincinnati Eye Institute, Cincinnati
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 6 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT07425574Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- Cincinnati Eye Institute, Cincinnati
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 50 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ኤፕሪ 2026 · NCT07064759Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Cleveland Clinic | Cole Eye Institute, Cleveland
ተሳታዮችን በመፈለግ ላይ
እድሜ 65 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ዲሴም 2024 · NCT05438732ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።